BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10708592)

  • 1. Cytoplasmic inhibitor of eEF-2 ADP-ribosylation catalyzed by diphtheria toxin or endogenous transferase in rat liver cells.
    Galicka A; Sredzińska K; Gindzieński A
    Biochem Biophys Res Commun; 2000 Mar; 269(2):553-6. PubMed ID: 10708592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous ADP-ribosylation for eukaryotic elongation factor 2: evidence of two different sites and reactions.
    Bektaş M; Nurten R; Ergen K; Bermek E
    Cell Biochem Funct; 2006; 24(4):369-80. PubMed ID: 16142694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous ADP-ribosylation of eukaryotic elongation factor 2 and its 32 kDa tryptic fragment.
    Ergen K; Bektaş M; Gökçe S; Nurten R
    Biocell; 2007; 31(1):61-6. PubMed ID: 17665640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actin--an inhibitor of eukaryotic elongation factor activities.
    Bektaş M; Günçer B; Güven C; Nurten R; Bermek E
    Biochem Biophys Res Commun; 2004 May; 317(4):1061-6. PubMed ID: 15094376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oxidative stress on in vivo ADP-ribosylation of eukaryotic elongation factor 2.
    Bektaş M; Akçakaya H; Aroymak A; Nurten R; Bermek E
    Int J Biochem Cell Biol; 2005 Jan; 37(1):91-9. PubMed ID: 15381153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transition state structure for ADP-ribosylation of eukaryotic elongation factor 2 catalyzed by diphtheria toxin.
    Parikh SL; Schramm VL
    Biochemistry; 2004 Feb; 43(5):1204-12. PubMed ID: 14756556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the endogenous ADP-ribosylation of wild-type and mutant elongation factor 2 in eukaryotic cells.
    Fendrick JL; Iglewski WJ; Moehring JM; Moehring TJ
    Eur J Biochem; 1992 Apr; 205(1):25-31. PubMed ID: 1313365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possibility of the transformation of eEF-2 (100 kDa) to eEF-2 (65 kDa) in the peptide elongation process in vitro.
    Gajko A; Sredzińska K; Galasiński W; Gindzieński A
    Biochem Biophys Res Commun; 1999 Feb; 255(2):535-8. PubMed ID: 10049743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships in diphtheria toxin and exotoxin A from Pseudomonas aeruginosa.
    Collier RJ; Gilliland DG; Lory S
    Prog Clin Biol Res; 1979; 31():751-9. PubMed ID: 119972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automodification of arginine-specific ADP-ribosyltransferase purified from chicken peripheral heterophils and alteration of the transferase activity.
    Yamada K; Tsuchiya M; Nishikori Y; Shimoyama M
    Arch Biochem Biophys; 1994 Jan; 308(1):31-6. PubMed ID: 8311468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the nature of cellular ADP-ribosyltransferase from rat liver specific for elongation factor 2.
    Sayhan O; Ozdemirli M; Nurten R; Bermek E
    Biochem Biophys Res Commun; 1986 Sep; 139(3):1210-4. PubMed ID: 3094526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eukaryotic elongation factor-2 (eEF-2) activity in bovine mammary tissue in relation to milk protein synthesis.
    Christophersen CT; Karlsen J; Nielsen MO; Riis B
    J Dairy Res; 2002 May; 69(2):205-12. PubMed ID: 12222799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADP-ribosylation of neurofilaments by a cytoplasmic ADP-ribose transferase associated with free mRNP.
    Jesser M; Hog F; Chypre C; Leterrier JF; Mandel P
    Biochem Biophys Res Commun; 1993 Jul; 194(2):916-22. PubMed ID: 8343173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating the ADP-ribosyltransferase activity of sirtuins with NAD analogues and 32P-NAD.
    Du J; Jiang H; Lin H
    Biochemistry; 2009 Apr; 48(13):2878-90. PubMed ID: 19220062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADP-ribosylation of the intermediate filament protein desmin and inhibition of desmin assembly in vitro by muscle ADP-ribosyltransferase.
    Huang HY; Graves DJ; Robson RM; Huiatt TW
    Biochem Biophys Res Commun; 1993 Dec; 197(2):570-7. PubMed ID: 8267592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of non-ADP-ribosylatable, diphtheria toxin-resistant elongation factor 2 in Saccharomyces cerevisiae.
    Kimata Y; Harashima S; Kohno K
    Biochem Biophys Res Commun; 1993 Mar; 191(3):1145-51. PubMed ID: 8466491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of diphtheria toxin-resistant cells by mutagen-carcinogens.
    Terada M; Nakayasu M; Sakamoto H; Nakasato F; Sugimura T
    Princess Takamatsu Symp; 1983; 13():277-86. PubMed ID: 6654830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction of additional charges as an aid in protein purification: isolation of elongation factor 2 from Sulfolobus acidocaldarius by preparative isoelectric focusing before and after ADP-ribosylation.
    Siegmund KD; Klink F
    Protein Expr Purif; 1994 Dec; 5(6):553-8. PubMed ID: 7858424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of 2'-deoxynad for ADP-ribose transfer reactions.
    Wasson DB; Yamanaka H; Carson DA
    Adv Exp Med Biol; 1989; 253B():213-8. PubMed ID: 2514587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of ADP-ribosylation sites on desmin and restoration of desmin intermediate filament assembly by de-ADP-ribosylation .
    Zhou H; Huiatt TW; Robson RM; Sernett SW; Graves DJ
    Arch Biochem Biophys; 1996 Oct; 334(2):214-22. PubMed ID: 8900395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.